Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid

NCT01571895 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class

Stopped Lack of efficacy observed at 1/3 of the enrollment at investigated dosage. No results available.

Conditions

Interventions

Sponsor

Dompé Farmaceutici S.p.A